Yoko Ogawara
-
- Cancer, Hypoxia, and Metabolism 4
-
- Histone Deacetylase Inhibitors Research 5
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
- Cancer-related gene regulation 2
- Protein Degradation and Inhibitors 2
-
- Acute Myeloid Leukemia Research 7
-
- Glioma Diagnosis and Treatment 4
- Co-authors
- Toshiyuki ObataShohei KishishitaNorihisa MasuyamaYukiko GotohKeiji TanakaToshiaki SuzukiIssay KitabayashiTakuo Katsumoto
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yoko Ogawara
12 papers receiving 580 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 118
- Oncology 213
- Molecular Biology 445
- Hematology 56
- Pathology and Forensic Medicine 52
Countries citing papers authored by Yoko Ogawara
This map shows the geographic impact of Yoko Ogawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Ogawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Ogawara more than expected).
Fields of papers citing papers by Yoko Ogawara
This network shows the impact of papers produced by Yoko Ogawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Ogawara. The network helps show where Yoko Ogawara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoko Ogawara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2019 | 2 | |
| 3 | 2018 | 20 | |
| 4 | The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model | 2016 | 0 |
| 5 | 2016 | 2 | |
| 6 | 2015 | 45 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 0 | |
| 9 | 2014 | 2 | |
| 10 | 2013 | 1 | |
| 11 | 2013 | 9 | |
| 12 | 2010 | 1 | |
| 13 | 2002 | 488 | |
| 14 | 2001 | 13 |
About Yoko Ogawara
Yoko Ogawara is a scholar working on Hematology, Genetics and Cancer Research, having authored 14 papers that have together received 591 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Glioma Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer-related gene regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (118 citations), Oncology (213 citations) and Molecular Biology (445 citations). Yoko Ogawara has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshiyuki Obata, Shohei Kishishita, Norihisa Masuyama, Yukiko Gotoh, Keiji Tanaka, Toshiaki Suzuki, Issay Kitabayashi, Takuo Katsumoto, Yuki Kagiyama and Yukiko Aikawa. Their work appears in journals such as Journal of Biological Chemistry, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.